Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,329 | -17,119 | -13,045 | -8,868 | -4,537 |
| Depreciation Amortization | 4 | -179 | -158 | -124 | 5 |
| Other Working Capital | -763 | 635 | -206 | 451 | 69 |
| Other Operating Activity | 316 | 986 | 524 | 228 | 88 |
| Operating Cash Flow | $-3,773 | $-15,677 | $-12,885 | $-8,313 | $-4,376 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,250 | 11,059 | 12,763 | 6,834 | 3,241 |
| PPE Investments | N/A | -2 | -2 | -1 | -1 |
| Investing Cash Flow | $4,250 | $11,057 | $12,761 | $6,833 | $3,239 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,638 | 972 | N/A | N/A |
| Other Financing Activity | 0 | -140 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $1,498 | $972 | $N/A | $N/A |
| Exchange Rate Effect | 18 | 33 | 31 | 31 | 3 |
| Beginning Cash Position | 4,423 | 7,511 | 7,511 | 7,511 | 7,511 |
| End Cash Position | 4,918 | 4,423 | 8,390 | 6,061 | 6,378 |
| Net Cash Flow | $495 | $-3,088 | $878 | $-1,450 | $-1,134 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,773 | -15,677 | -12,885 | -8,313 | -4,376 |
| Capital Expenditure | N/A | -2 | -2 | -1 | -1 |
| Free Cash Flow | -3,773 | -15,679 | -12,887 | -8,314 | -4,377 |